Roubaix Capital’s MaxCyte MXCT Stock Holding History

Roubaix Capital’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-427,515	Closed	-$1.66M	–	57
2024 Q3	$1.66M	Buy	427,515 +12,697	+3%	+$53.5K	0.92%	44
2024 Q2	$1.63M	Sell	414,818 -82,535	-17%	-$355K	1.03%	42
2024 Q1	$2.08M	Buy	497,353 +111,152	+29%	+$522K	1.32%	35
2023 Q4	$1.82M	Buy	+386,201	New	+$1.5M	1.27%	33

Other funds holding MXCT

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

RGI

River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Roubaix Capital's MXCT Position: Q4 2024 in Review

Roubaix Capital sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 427,515 shares — an estimated $1.66M sold.

Roubaix Capital first reported a position in MXCT in Q4 2023 and held it in 4 quarters. The position peaked at $2.08M in Q1 2024. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.

Roubaix Capital reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
Roubaix Capital sold 427,515 MaxCyte shares in Q4 2024, an estimated $1.66M.
Roubaix Capital first reported a position in MaxCyte in Q4 2023 and held it in 4 quarters.
Roubaix Capital's MaxCyte position peaked at $2.08M in Q1 2024.
119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.

Based on Roubaix Capital's 13F filing for Q4 2024, filed 13 Feb 2025.